In Vitro Transcription and RNA Research |
In Vitro Transcription Kits
Order
| Protocol
| Citations
| Related Products
Applications
- High-yield synthesis of RNase A-resistant RNA for in situ hybridization,
ribonuclease protection assays, RNA interference (RNAi),1 ribozyme
studies, and antisense RNA studies.
The DuraScribe® T7 and SP6 Transcription Kits* produce 2´-fluorine-modified
RNA transcripts—called DuraScript® RNA—that are completely
resistant to RNase A (Fig. 1).1 DuraScript RNA is more stable
in storage and in all RNA applications, and can be made and used without
the tedious procedures normally required for keeping RNA transcripts
intact. Research indicates that double-stranded DuraScript RNA can be
delivered into cultured mammalian cells in the presence of serum and
without the need for transfection reagents.2 Double-stranded
oligonucleotides, linearized plasmids, or PCR products with a T7 or SP6
promoter can be transcribed in a DuraScribe transcription reaction.
The DuraScribe T7 and SP6 RNA Polymerases provided in the kits efficiently
incorporate 2´-Fluorine-CTP (2´-F-dCTP) and 2´-Fluorine-UTP
(2´-F-dUTP), as well as ATP and GTP into full length transcripts.
The standard 20-µl DuraScribe reaction, using 1 µg of DNA
template, produces approximately 50 µg of DuraScript RNA (Fig.
2). The DuraScribe T7 and SP6 RNA Polymerases recognize the same T7 and
SP6 transcription promoters as standard T7 and SP6 RNA Polymerases.
Benefits
- DuraScript RNA is completely resistant to RNase A and to the nucleases
found on human skin.
- No need for gloves, DEPC-treatment of reagents, or RNase inhibitors
when making or working with DuraScript RNA.
- Double-stranded DuraScript RNA is taken up by cultured mammalian
cells in the presence of serum and without the need for transfection
reagents.2
- Fluorescently labeled DuraScribe RNA can be readily produced.
|

Figure 1. DuraScript® RNA is resistant to RNase A digestion. A
1.4-kb standard RNA transcript and a 1.4-kb DuraScript RNA transcript
were each incubated with 1 U of highly purified RNase A for 30 minutes.
The standard RNA transcript was completely degraded while the DuraScript
RNA transcript remained intact. Lane M, size ladder; lane 1, 1.4-kb standard
RNA transcript; lane 2, standard RNA after RNase A treatment; lane 3,
1.4-kb DuraScript RNA; lane 4, DuraScript RNA after RNase A treatment. |

Figure 2. Yield of RNA from a DuraScribe® T7 Transcription reaction. A
standard reaction (4-6 hours) produced 40-60 µg of a 1.4-kb DuraScript® RNA. |

Figure 3 (click to enlarge). DuraScribe® T7 and SP6 RNA Polymerases
efficiently incorporate 2´-F-dCTP and 2´-F-dUTP into full
length DuraScript® RNA. The presence of the fluorine at the
2´-position of the 2´-F-dC and 2´-F-dU nucleotides
prevents RNase A digestion. The result is DuraScript® RNA that
is completely resistant to RNase A and related ribonucleases. |
 |
Figure 4. DuraScript® RNA is completely resistant to "finger" nucleases. A
1.4-kb standard RNA transcript and a 1.4-kb DuraScript RNA transcript were
produced using sterile water or water that had been contaminated by exposure
to the hands of a test subject. The standard RNA shows extensive degradation
from "finger" nucleases in the contaminated water while the DuraScript
RNA remains fully intact. M, Size ladder; Lane 1, Standard RNA transcript;
Lane 2, Standard RNA after "finger" nuclease exposure; Lane 3,
DuraScript RNA; Lane 4, DuraScript RNA after "finger" nuclease
exposure. |
 |
Figure 5. DuraScript® RNA is stable in tissue culture media for
at least 2 hours. Five micrograms of a 1.4-kb standard RNA transcript
and a DuraScript RNA transcript were incubated in 100 µl of tissue
culture media (D-MEM + 10% fetal calf serum) at 37°C. Lane 1, RNA
ladder; Lane 2, standard RNA; Lane 3, standard RNA after 15 minutes in
tissue culture media; Lane 4, DuraScript RNA; Lanes 5-8 DuraScript RNA
after 15, 30, 60, and 120 minutes, respectively, in tissue culture media. |
References
- Capodici, J. et al. (2002) J. Immunol. 169, 5196.
- Meis, J. and Chen, F. (2002) EPICENTRE Forum 9(1), 10.
* Covered by issued and/or pending patents.
AmpliScribe™ T7, T3, and SP6 High Yield Transcription Kits
[top of page]
|